UpHealth Group Income Statement

Financials in millions SGD. Fiscal year is January - December.

Millions SGD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	-	-	-	37.94	30.94
Revenue Growth (YoY)	-	-	-	22.60%	-0.17%
Cost of Revenue	-	-	-	36.38	17.19
Gross Profit	-	-	-	1.56	13.75
Selling, General & Admin	6.1	6.79	1.82	3.28	3.19
Other Operating Expenses	0.19	0.52	-1.27	0.14	-0.24
Operating Expenses	6.3	7.31	0.54	3.45	2.98
Operating Income	-6.3	-7.31	-0.54	-1.89	10.78
Interest Expense	-	-	-	-1.83	-1.28
Interest & Investment Income	4.18	3.38	0.03	0.32	0.17
Currency Exchange Gain (Loss)	0.94	-0.69	-0.12	-0	0.07
Other Non Operating Income (Expenses)	-0.2	-	-	0.57	0.25
EBT Excluding Unusual Items	-1.37	-4.62	-0.64	-2.84	9.99
Gain (Loss) on Sale of Assets	-	-	-	0.03	0.05
Asset Writedown	-	-	-	0.87	-2.05
Other Unusual Items	-	-	-	0.16	2.63
Pretax Income	-1.37	-4.62	-0.64	-1.78	10.61
Income Tax Expense	-	-	0.14	0.19	0.28
Earnings From Continuing Operations	-1.37	-4.62	-0.78	-1.97	10.33
Earnings From Discontinued Operations	-	-18.1	-3.51	-	-
Net Income to Company	-1.37	-22.72	-4.29	-1.97	10.33
Minority Interest in Earnings	-	0	0.01	-0.02	-0.01
Net Income	-1.37	-22.72	-4.27	-1.98	10.32
Net Income to Common	-1.37	-22.72	-4.27	-1.98	10.32
Net Income Growth	-	-	-	-	18.69%
Shares Outstanding (Basic)	150	150	150	150	150
Shares Outstanding (Diluted)	150	150	150	150	150
Shares Change (YoY)	-	-	-	-	1.71%
EPS (Basic)	-0.01	-0.15	-0.03	-0.01	0.07
EPS (Diluted)	-0.01	-0.15	-0.03	-0.01	0.07
EPS Growth	-	-	-	-	16.69%
Free Cash Flow	-6.32	-12.06	1.28	-2.45	-0.66
Free Cash Flow Per Share	-0.04	-0.08	0.01	-0.02	-0.00
Dividend Per Share	-	-	-	-	0.009
Dividend Growth	-	-	-	-	-26.72%
Gross Margin	-	-	-	4.12%	44.44%
Operating Margin	-	-	-	-4.98%	34.82%
Profit Margin	-	-	-	-5.23%	33.35%
Free Cash Flow Margin	-	-	-	-6.45%	-2.13%
EBITDA	-5.04	-6.05	1.87	0.92	12.81
EBITDA Margin	-	-	-	2.43%	41.39%
D&A For EBITDA	1.26	1.26	2.42	2.81	2.03
EBIT	-6.3	-7.31	-0.54	-1.89	10.78
EBIT Margin	-	-	-	-4.98%	34.82%
Effective Tax Rate	-	-	-	-	2.64%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.